1,720,958 research outputs found
Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry
Full text linkAims: We examine the effects of symptoms and cardiovascular disease (CVD) events on health-related quality of life (HRQOL) and healthcare costs in a European population with atrial fibrillation (AF). Methods and results: In the EURObservational Research Programme on AF long-term general registry, AF patients from 250 centres in 27 European countries were enrolled and followed for 2 years. We used fixed effects models to estimate the association of symptoms and CVD events on HRQOL and annual healthcare costs. We found significant decrements in HRQOL in AF patients in whom ST-segment elevation myocardial infarction (STEMI) [−0.075 (95% confidence interval −0.144, −0.006)], angina or non-ST-elevation myocardial infarction (NSTEMI) [−0.037 (−0.071, −0.003)], new-onset/worsening heart failure [−0.064 (−0.088, −0.039)], bleeding events [−0.031 (−0.059, −0.003)], thromboembolic events [−0.071 (−0.115, −0.027)], mild symptoms [0.037 (−0.048, −0.026)], or severe/disabling symptoms [−0.090 (−0.108, −0.072)] occurred during the follow-up. During follow-up, annual healthcare costs were associated with an increase of €11 718 (€8497, €14 939) in patients with STEMI, €5823 (€4757, €6889) in patients with angina/NSTEMI, €3689 (€3219, €4158) in patients with new-onset or worsening heart failure, €3792 (€3315, €4270) in patients with bleeding events, and €3182 (€2483, €3881) in patients with thromboembolic events, compared with AF patients without these events. Healthcare costs were primarily driven by inpatient costs. There were no significant differences in HRQOL or healthcare resource use between EU regions or by sex. Conclusion: Symptoms and CVD events are associated with a high burden on AF patients and healthcare systems throughout Europe
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
Contributions of injury deaths to changes in life expectancy and disparity : A comparative analysis of G7 countries over two decades
No full textBACKGROUND: Despite the high level of economic development in the Group of Seven (G7) countries, injury deaths remain a public health concern in these countries. This paper examines the contribution of injury deaths to changes in life expectancy (LE) and life disparity (LD) in the G7 countries.METHODS: We used annual data from the WHO mortality database to compute LE and LD during 2001-03 and 2017-19. The contributions of injury deaths to LE and LD changes for each sex were decomposed by age and cause using a continuous-change model.RESULTS: Across the G7 countries combined, LE (LD) increased by 2.12 (0.25) and 2.73 (0.16) years for females and males, respectively. While most injury-related deaths contributed to increases in LE and decreases in LD, these gains were offset by negative contributions of unintentional poisoning, resulting in an overall negligible net contributions of injury deaths to changes in LE/LD across the G7 countries combined. The country-specific patterns revealed notable variations. Positive contributions of injury-related causes to changes in LE were more prominent in France (+ 0.38/+0.64 years for females/males), while negative contributions were most evident in the USA (-0.23/-0.42 years for females/males). Transport accidents emerged as the leading contributors to improvements in both LE and LD among both sexes in all countries, with more pronounced effects in males. In contrast, unintentional poisoning had a substantial negative impact, particularly among younger populations in the USA, UK, and Canada.CONCLUSION: Injury deaths made negligible contributions to overall changes in LE and LD across the G7 countries combined during the study period. However, there were important variations by sex, age, cause and country. Specifically, unfavourable contributions of injury deaths were mainly observed in the USA, UK, and Canada. These findings highlight the need for targeted, country-specific injury prevention strategies to mitigate premature and unequal mortality
Improving Injectable Medicines Prescription in Outpatient Services: A Path Towards Rational Use of Medicines in Iran
Full text linkInjection is one of the most common medical procedures in the health sector. Annually up to 16 billion injections are
prescribed in low- and middle-income countries (LMICs), many of them are not necessary for the patients, increase
the healthcare costs and may result in side effects. Currently over 40% of outpatient prescriptions in Iran contain at
least one injectable medicine. To address the issue, a working group was established (August 2014 to April 2015) to
provide a comprehensive policy brief to be used by national decision-makers. This report is the extract of methods
that were followed and the main policy options for improving injectable medicines prescribing in outpatient services.
Thirty-three potential policy options were developed focusing on different stakeholders. The panel reached consensus
on seven policy options, noting effectiveness, cost, durability, and feasibility of each policy. The recommended policy
options are targeted at patients and public (2 policies), insurers (2), physicians (1), pharmacies (1), and the Ministry
of Health and Medical Education (MoHME) (1)
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
- …
